Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial

Phase: PHASE2 | Sponsor: Johns Hopkins University | Compound: Psilocybin

Status

recruiting

Institution

Johns Hopkins University

Start date

2024-02-08

End date

2029-05-01

Registry ID

NCT06067737

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.